M44 Growth Hormone Deficiency

Program: Meet-the-Professor Sessions
Clinical Session
Sunday, April 3, 2016: 3:30 PM-4:15 PM
Room 109 (BCEC)
Ulla Feldt-Rasmussen, Professor, MD, DMSc, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark

UF: Principal Investigator, Novo Nordisk, Ad Hoc Consultant, Novo Nordisk, Advisory Group Member, Pfizer, Inc..


The Endocrine Society would like to thank the following organizations for their support: AbbVie Inc.; Bayer HealthCare Pharmaceuticals Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; Chiasma, Inc.; Corcept Therapeutics Incorporated; Eisai, Inc.; Ethicon Endo-Surgery, Inc.; Genzyme, a Sanofi company, Ipsen Biopharmaceuticals, Inc.; Leona M. and Harry B. Helmsley Charitable Trust; Lilly USA, LLC; Medtronic Diabetes; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; Novo Nordisk Inc.; Pfizer, Inc.; Shire